Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs NextEra Energy, Inc. (NEE) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
NextEra Energy, Inc.Trade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs NextEra Energy, Inc. — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.66 (market cap $29.60B), while NextEra Energy, Inc. trades at $85.83 (market cap $178.85B). The key difference: NextEra Energy, Inc. is far larger — about 6× Alnylam Pharmaceuticals, Inc.'s market cap, and NextEra Energy, Inc. pays a 2.91% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.

ALNYNEE
Market Cap
$29.60B$178.85B
Sector
HealthUtilities
52-Week High
$491.22$97.88
52-Week Low
$205.48$69.77
Enterprise Value
$27.56B$286.18B
Dividend Yield
2.91%

Returns comparison

Trailing returns across standard periods

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About NextEra Energy, Inc.

NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.

Read more on NEE